carbon tetrachloride has been researched along with Liver Failure in 34 studies
Carbon Tetrachloride: A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed)
tetrachloromethane : A chlorocarbon that is methane in which all the hydrogens have been replaced by chloro groups.
Liver Failure: Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)
Excerpt | Relevance | Reference |
---|---|---|
" Then, we examined possible in vivo hepatoprotective effects of EP extract on mouse models of carbon tetrachloride (CCl4)-induced chronic and acute liver failure." | 7.80 | Protective effects of Ephedra pachyclada extract on mouse models of carbon tetrachloride- induced chronic and acute liver failure. ( Azarnia, M; Ghasemi, M; Jamali, M; Mirabolghasemi, G; Naghizadeh, MM; Nazarian, S; Rajabi, M; Tahamtani, Y, 2014) |
"The influence of chronic hepatic failure on the disposition kinetics of valproate (VPA) excretion via a phase II reaction was examined in rats treated with carbon tetrachloride (1." | 7.74 | Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride. ( Ishizaki, J; Khemawoot, P; Maruyama, C; Miyamoto, K; Noda, H; Tsukada, H; Yokogawa, K, 2007) |
"The aim of this study was to investigate the pharmacokinetic changes of verapamil and its major metabolite, norverapamil, after oral administration of verapamil (10 mg/kg) in rabbits with slight, moderate and severe hepatic failure induced by carbon tetrachloride." | 7.73 | Pharmacokinetics of verapamil and its major metabolite, norverapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride. ( Burm, JP; Choi, JS, 2005) |
"The efficiency of a new bioartificial liver (BAL) containing small tissue fragments in the treatment of acute hepatic failure induced by carbon tetrachloride in rats was evaluated." | 7.72 | A novel bioartificial liver containing small tissue fragments: efficiency in the treatment of acute hepatic failure induced by carbon tetrachloride in rats. ( Akatov, V; Ghaffar, TY; Ghaffar, YA; Hassan, AN; Lezhnev, E; Soloviev, V, 2003) |
") was investigated in rabbits with carbon tetrachloride-induced hepatic failure." | 7.71 | Pharmacokinetics of paclitaxel in rabbits with carbon tetrachloride-induced hepatic failure. ( Choi, JS, 2002) |
"To predict the potential utility of calcitriol in human osteoporosis with hepatic dysfunction, we examined the effects of calcitriol and alfacalcidol in ovariectomized (OVX) aged-rats with CCl4-induced hepatic failure." | 7.70 | [Effects of calcitriol and alfacalcidol on an osteoporosis model in rats with hepatic failure]. ( Ishibashi, Y; Kojima, E; Kuriyama, K; Kusajima, H; Momo, K; Tachiiri, T; Yamanishi, A, 1999) |
" Carbon tetrachloride (CCl4) was used to induce liver failure, and 5/6th nephrectomy in combination with a high-phosphate diet was used to induce chronic kidney disease (CKD)." | 4.90 | EXTL2 controls liver regeneration and aortic calcification through xylose kinase-dependent regulation of glycosaminoglycan biosynthesis. ( Kitagawa, H; Nadanaka, S, 2014) |
" Upon transplantation into mice with carbon tetrachloride (CCl4)-induced acute fulminant liver failure, iHeps restore the liver function and prolong survival." | 3.81 | Rapid and high-efficiency generation of mature functional hepatocyte-like cells from adipose-derived stem cells by a three-step protocol. ( Chen, X; Cheng, F; Cheng, L; Deng, H; Deng, J; Fu, Y; Huang, M; Liu, J; Wang, Y; Wei, Y; Xu, F; Xu, P; Yao, Y; Yu, D; Zhang, Y, 2015) |
" Then, we examined possible in vivo hepatoprotective effects of EP extract on mouse models of carbon tetrachloride (CCl4)-induced chronic and acute liver failure." | 3.80 | Protective effects of Ephedra pachyclada extract on mouse models of carbon tetrachloride- induced chronic and acute liver failure. ( Azarnia, M; Ghasemi, M; Jamali, M; Mirabolghasemi, G; Naghizadeh, MM; Nazarian, S; Rajabi, M; Tahamtani, Y, 2014) |
"Human MSCs labeled with FDA-approved SPIO particles (Feridex) were transplanted via the mesenteric vein into rabbits (n = 16) with carbon tetrachloride-induced hepatic failure." | 3.76 | MRI of magnetically labeled mesenchymal stem cells in hepatic failure model. ( Choi, SH; Chung, SY; Kim, HC; Kim, HS; Lee, JM; Moon, WK; Son, KR, 2010) |
" plantarum strains were administered in ornithine transcarbamoylase-deficient Sparse-fur mice, a model of constitutive hyperammonemia, in a carbon tetrachloride rat model of chronic liver insufficiency and in a thioacetamide-induced acute liver failure mice model." | 3.74 | Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents. ( Demetter, P; Devière, J; Goffin, P; Gustot, T; Hols, P; Moreno, C; Nicaise, C; Prozzi, D; Quertinmont, E; Suain, V; Viaene, E, 2008) |
" In our present study, an ultraperformance liquid chromatography-mass spectrometry (UPLC-MS) method has been established and validated for simultaneous quantitation of 22 BAs and a metabonomic study was performed based on the chemometric analysis of the serum samples from carbon tetrachloride (CCl4)- and alpha-naphthylisothiocyanate (ANIT)-induced liver failure rats." | 3.74 | Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry. ( He, Y; Hu, Z; Li, W; Wang, C; Wang, Z; Xiong, A; Yang, L, 2008) |
"The influence of chronic hepatic failure on the disposition kinetics of valproate (VPA) excretion via a phase II reaction was examined in rats treated with carbon tetrachloride (1." | 3.74 | Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride. ( Ishizaki, J; Khemawoot, P; Maruyama, C; Miyamoto, K; Noda, H; Tsukada, H; Yokogawa, K, 2007) |
"These results suggested that not only hepatic failure but also renal failure could modify the pharmacokinetics of paclitaxel in vivo." | 3.73 | Altered pharmacokinetics of paclitaxel in experimental hepatic or renal failure. ( Inui, K; Jiko, M; Okuda, M; Yano, I, 2005) |
"The aim of this study was to investigate the pharmacokinetic changes of verapamil and its major metabolite, norverapamil, after oral administration of verapamil (10 mg/kg) in rabbits with slight, moderate and severe hepatic failure induced by carbon tetrachloride." | 3.73 | Pharmacokinetics of verapamil and its major metabolite, norverapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride. ( Burm, JP; Choi, JS, 2005) |
"The efficiency of a new bioartificial liver (BAL) containing small tissue fragments in the treatment of acute hepatic failure induced by carbon tetrachloride in rats was evaluated." | 3.72 | A novel bioartificial liver containing small tissue fragments: efficiency in the treatment of acute hepatic failure induced by carbon tetrachloride in rats. ( Akatov, V; Ghaffar, TY; Ghaffar, YA; Hassan, AN; Lezhnev, E; Soloviev, V, 2003) |
") was investigated in rabbits with carbon tetrachloride-induced hepatic failure." | 3.71 | Pharmacokinetics of paclitaxel in rabbits with carbon tetrachloride-induced hepatic failure. ( Choi, JS, 2002) |
"To predict the potential utility of calcitriol in human osteoporosis with hepatic dysfunction, we examined the effects of calcitriol and alfacalcidol in ovariectomized (OVX) aged-rats with CCl4-induced hepatic failure." | 3.70 | [Effects of calcitriol and alfacalcidol on an osteoporosis model in rats with hepatic failure]. ( Ishibashi, Y; Kojima, E; Kuriyama, K; Kusajima, H; Momo, K; Tachiiri, T; Yamanishi, A, 1999) |
"The effect of CCl4-induced experimental hepatic failure (EHF) on the sequential hepatobiliary transport of model organic cations (OCs), triethylmethylammonium (TEMA), and tributylmethylammonium (TBuMA), was investigated in rats." | 3.70 | Functional impairment of sinusoidal membrane transport of organic cations in rats with CCl4-induced hepatic failure. ( Chung, SJ; Hong, SS; Shim, CK, 2000) |
" Both conditions failed to cause a significant effect on Cmax or Tmax." | 1.40 | Effect of experimentally induced hepatic and renal failure on the pharmacokinetics of topiramate in rats. ( Matar, KM; Tayem, YI, 2014) |
"Chronic kidney disease, end-stage renal failure, and liver diseases are increasing worldwide and constitute a huge burden on health care costs, with attendant high morbidity and debility." | 1.40 | Hepato- and nephroprotective activities of a Nigerian local king tuber oyster mushroom, Pleurotus tuberregium (higher Basidiomycetes), in chemically induced organ toxicities in rats. ( Akah, PA; Ihim, SA; Laiyemo, KA; Nworu, CS; Ugwu, LE, 2014) |
"Liver cirrhosis was induced by intraperitoneal administration of CCl4 at a dose of 0." | 1.33 | Cryopreserved fetal liver cell transplants support the chronic failing liver in rats with CCl4-induced cirrhosis. ( Fuller, BJ; Mazur, SP; Ochenashko, OV; Petrenko, AY; Somov, AY; Volkova, NA, 2006) |
" In this study, we searched for new biochemical indicators that correlate with hepatic function and tried to simulate appropriate drug dosage in chronic hepatic failure." | 1.33 | Development of dosage design of hepatic metabolizing drugs using serum albumin level in chronic hepatic failure. ( Kurihara, T; Mano, Y; Miyamoto, K; Nomura, M; Tsukada, H; Yokogawa, K, 2006) |
"Glycogen stores were depleted by acute intoxication with CCl(4)." | 1.31 | Kupffer cells inhibition prevents hepatic lipid peroxidation and damage induced by carbon tetrachloride. ( Alba, N; Muriel, P; Pérez-Alvarez, VM; Shibayama, M; Tsutsumi, VK, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.94) | 18.7374 |
1990's | 3 (8.82) | 18.2507 |
2000's | 19 (55.88) | 29.6817 |
2010's | 11 (32.35) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nadanaka, S | 1 |
Kitagawa, H | 1 |
Ghasemi, M | 1 |
Azarnia, M | 1 |
Jamali, M | 1 |
Mirabolghasemi, G | 1 |
Nazarian, S | 1 |
Naghizadeh, MM | 1 |
Rajabi, M | 1 |
Tahamtani, Y | 1 |
Matar, KM | 1 |
Tayem, YI | 1 |
Chen, KT | 1 |
Pernelle, K | 1 |
Tsai, YH | 1 |
Wu, YH | 1 |
Hsieh, JY | 1 |
Liao, KH | 1 |
Guguen-Guillouzo, C | 1 |
Wang, HW | 2 |
Nworu, CS | 1 |
Ihim, SA | 1 |
Ugwu, LE | 1 |
Laiyemo, KA | 1 |
Akah, PA | 1 |
Xu, F | 1 |
Liu, J | 1 |
Deng, J | 1 |
Chen, X | 1 |
Wang, Y | 1 |
Xu, P | 1 |
Cheng, L | 1 |
Fu, Y | 1 |
Cheng, F | 1 |
Yao, Y | 1 |
Zhang, Y | 1 |
Huang, M | 1 |
Yu, D | 1 |
Wei, Y | 1 |
Deng, H | 1 |
Zhou, X | 2 |
Cui, L | 1 |
Yang, Q | 1 |
Wang, L | 1 |
Guo, G | 1 |
Hou, Y | 1 |
Cai, W | 1 |
Han, Z | 1 |
Shi, Y | 1 |
Han, Y | 1 |
Nicaise, C | 1 |
Prozzi, D | 1 |
Viaene, E | 1 |
Moreno, C | 1 |
Gustot, T | 1 |
Quertinmont, E | 1 |
Demetter, P | 1 |
Suain, V | 1 |
Goffin, P | 1 |
Devière, J | 1 |
Hols, P | 1 |
Yang, L | 2 |
Xiong, A | 1 |
He, Y | 1 |
Wang, Z | 2 |
Wang, C | 1 |
Li, W | 1 |
Hu, Z | 1 |
Boer, LA | 1 |
Panatto, JP | 1 |
Fagundes, DA | 1 |
Bassani, C | 1 |
Jeremias, IC | 1 |
Daufenbach, JF | 1 |
Rezin, GT | 1 |
Constantino, L | 1 |
Dal-Pizzol, F | 1 |
Streck, EL | 1 |
Tomić, A | 1 |
Bozin, B | 1 |
Samojlik, I | 1 |
Milenković, M | 1 |
Mimica-Dukić, N | 1 |
Petrović, S | 1 |
Son, KR | 1 |
Chung, SY | 1 |
Kim, HC | 1 |
Kim, HS | 1 |
Choi, SH | 1 |
Lee, JM | 1 |
Moon, WK | 1 |
Li, J | 1 |
Gao, J | 1 |
Yan, D | 1 |
Yuan, Y | 1 |
Sah, S | 1 |
Satyal, U | 1 |
Liu, M | 1 |
Han, W | 1 |
Yu, Y | 1 |
Chen, YF | 1 |
Tseng, CY | 1 |
Kuo, HC | 1 |
Yang, VW | 1 |
Lee, OK | 1 |
Choi, JS | 2 |
Streetz, KL | 1 |
Tacke, F | 1 |
Leifeld, L | 1 |
Wüstefeld, T | 1 |
Graw, A | 1 |
Klein, C | 1 |
Kamino, K | 1 |
Spengler, U | 1 |
Kreipe, H | 1 |
Kubicka, S | 1 |
Müller, W | 1 |
Manns, MP | 1 |
Trautwein, C | 1 |
REYNELL, PC | 1 |
Soloviev, V | 1 |
Hassan, AN | 1 |
Akatov, V | 1 |
Lezhnev, E | 1 |
Ghaffar, TY | 1 |
Ghaffar, YA | 1 |
Honda, T | 1 |
Fukuda, Y | 1 |
Nakano, I | 1 |
Katano, Y | 1 |
Goto, H | 1 |
Nagasaki, M | 1 |
Sato, Y | 1 |
Murakami, T | 1 |
Shimomura, Y | 1 |
Jiko, M | 1 |
Yano, I | 1 |
Okuda, M | 1 |
Inui, K | 1 |
Burm, JP | 1 |
Ochenashko, OV | 1 |
Volkova, NA | 1 |
Mazur, SP | 1 |
Somov, AY | 1 |
Fuller, BJ | 1 |
Petrenko, AY | 1 |
Nardo, B | 1 |
Caraceni, P | 1 |
Puviani, L | 1 |
Pertosa, AM | 1 |
Domenicali, M | 1 |
Pariali, M | 1 |
Angiolini, G | 1 |
Chieco, P | 1 |
Trevisani, F | 1 |
Bernardi, M | 1 |
Cavallari, A | 1 |
Mano, Y | 1 |
Tsukada, H | 2 |
Kurihara, T | 1 |
Nomura, M | 1 |
Yokogawa, K | 2 |
Miyamoto, K | 2 |
Khemawoot, P | 1 |
Maruyama, C | 1 |
Noda, H | 1 |
Ishizaki, J | 1 |
Yuasa, T | 1 |
Yamamoto, T | 1 |
Rivas-Carrillo, JD | 1 |
Chen, Y | 1 |
Navarro-Alvarez, N | 1 |
Soto-Guiterrez, A | 1 |
Noguchi, H | 1 |
Matsumoto, S | 1 |
Tanaka, N | 1 |
Kobayashi, N | 2 |
Iijima, K | 1 |
Kiyohara, H | 1 |
Tanaka, M | 1 |
Matsumoto, T | 1 |
Cyong, JC | 1 |
Yamada, H | 1 |
Yamanishi, A | 1 |
Ishibashi, Y | 1 |
Kuriyama, K | 1 |
Tachiiri, T | 1 |
Kusajima, H | 1 |
Kojima, E | 1 |
Momo, K | 1 |
Hashimoto, M | 1 |
Watanabe, G | 1 |
Hong, SS | 1 |
Chung, SJ | 1 |
Shim, CK | 1 |
Ito, M | 1 |
Nakamura, J | 1 |
Cai, J | 1 |
Cao, C | 1 |
Hammel, JM | 1 |
Fox, IJ | 1 |
Koniaris, LG | 1 |
Zimmers-Koniaris, T | 1 |
Hsiao, EC | 1 |
Chavin, K | 1 |
Sitzmann, JV | 1 |
Farber, JM | 1 |
Datta, S | 1 |
Bhattacharyya, P | 1 |
Muriel, P | 1 |
Alba, N | 1 |
Pérez-Alvarez, VM | 1 |
Shibayama, M | 1 |
Tsutsumi, VK | 1 |
1 review available for carbon tetrachloride and Liver Failure
Article | Year |
---|---|
EXTL2 controls liver regeneration and aortic calcification through xylose kinase-dependent regulation of glycosaminoglycan biosynthesis.
Topics: Animals; Aorta; Calcinosis; Carbon Tetrachloride; Cell Differentiation; Glycosaminoglycans; Humans; | 2014 |
33 other studies available for carbon tetrachloride and Liver Failure
Article | Year |
---|---|
Protective effects of Ephedra pachyclada extract on mouse models of carbon tetrachloride- induced chronic and acute liver failure.
Topics: Acute Disease; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Che | 2014 |
Effect of experimentally induced hepatic and renal failure on the pharmacokinetics of topiramate in rats.
Topics: Animals; Anti-Obesity Agents; Antineoplastic Agents; Carbon Tetrachloride; Carbon Tetrachloride Pois | 2014 |
Liver X receptor α (LXRα/NR1H3) regulates differentiation of hepatocyte-like cells via reciprocal regulation of HNF4α.
Topics: Animals; Carbon Tetrachloride; Cell Differentiation; Cell Line; Cell Transplantation; Disease Models | 2014 |
Hepato- and nephroprotective activities of a Nigerian local king tuber oyster mushroom, Pleurotus tuberregium (higher Basidiomycetes), in chemically induced organ toxicities in rats.
Topics: Acetaminophen; Animals; Anti-Bacterial Agents; Carbon Tetrachloride; Complex Mixtures; Disease Model | 2014 |
Rapid and high-efficiency generation of mature functional hepatocyte-like cells from adipose-derived stem cells by a three-step protocol.
Topics: Abdominal Fat; Adult Stem Cells; Animals; Carbon Tetrachloride; Cell Differentiation; Cells, Culture | 2015 |
Induction of hepatocyte-like cells from human umbilical cord-derived mesenchymal stem cells by defined microRNAs.
Topics: Animals; Carbon Tetrachloride; Cell Transdifferentiation; Hepatocytes; Humans; Liver Failure; Mesenc | 2017 |
Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents.
Topics: Acute Disease; Alanine; Ammonia; Animals; Carbon Tetrachloride; Chronic Disease; Disease Models, Ani | 2008 |
Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry.
Topics: 1-Naphthylisothiocyanate; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bile Acids and | 2008 |
Inhibition of mitochondrial respiratory chain in the brain of rats after hepatic failure induced by carbon tetrachloride is reversed by antioxidants.
Topics: Animals; Antioxidants; Brain; Carbon Tetrachloride; Electron Transport; Electron Transport Chain Com | 2009 |
Effects of Athamanta turbith fruit essential oils on CCl4-induced hepatic failure in mice and their antioxidant properties.
Topics: Animals; Antioxidants; Apiaceae; Biphenyl Compounds; Carbon Tetrachloride; Free Radical Scavengers; | 2010 |
MRI of magnetically labeled mesenchymal stem cells in hepatic failure model.
Topics: Animals; Carbon Tetrachloride; Cell Movement; Cells, Cultured; Contrast Media; Dextrans; Disease Mod | 2010 |
Neutralization of chemokine CXCL14 (BRAK) expression reduces CCl4 induced liver injury and steatosis in mice.
Topics: Animals; Antibodies, Neutralizing; Carbon Tetrachloride; Cell Proliferation; Chemical and Drug Induc | 2011 |
Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol.
Topics: Animals; Carbon Tetrachloride; Cell Differentiation; Cell Lineage; Cell Transplantation; Cells, Cult | 2012 |
Pharmacokinetics of paclitaxel in rabbits with carbon tetrachloride-induced hepatic failure.
Topics: Animals; Carbon Tetrachloride; Liver Failure; Male; Paclitaxel; Rabbits | 2002 |
Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.
Topics: Acute Disease; Adolescent; Adult; Aged; Animals; Antigens, CD; Carbon Tetrachloride; Cell Division; | 2003 |
Therapy in experimental hepatic failure.
Topics: Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Liver; Liver Failure | 1955 |
A novel bioartificial liver containing small tissue fragments: efficiency in the treatment of acute hepatic failure induced by carbon tetrachloride in rats.
Topics: Amino Acids; Animals; Bioreactors; Blood Chemical Analysis; Carbon Tetrachloride; Equipment Design; | 2003 |
Effects of liver failure on branched-chain alpha-keto acid dehydrogenase complex in rat liver and muscle: comparison between acute and chronic liver failure.
Topics: 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); Amino Acids, Branched-Chain; Animals; Carbon Tetr | 2004 |
Altered pharmacokinetics of paclitaxel in experimental hepatic or renal failure.
Topics: Animals; Carbon Tetrachloride; Cytochrome P-450 Enzyme System; Liver Failure; Male; Metabolic Cleara | 2005 |
Pharmacokinetics of verapamil and its major metabolite, norverapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride.
Topics: Administration, Oral; Animals; Biological Availability; Calcium Channel Blockers; Carbon Tetrachlori | 2005 |
Cryopreserved fetal liver cell transplants support the chronic failing liver in rats with CCl4-induced cirrhosis.
Topics: Animals; Carbon Tetrachloride; Chronic Disease; Cryopreservation; Cytochrome P-450 Enzyme System; Di | 2006 |
Successful treatment of CCl4-induced acute liver failure with portal vein arterialization in the rat.
Topics: Alanine Transaminase; Analysis of Variance; Animals; Aspartate Aminotransferases; Carbon Tetrachlori | 2006 |
Development of dosage design of hepatic metabolizing drugs using serum albumin level in chronic hepatic failure.
Topics: Animals; Carbon Tetrachloride; Chronic Disease; Liver; Liver Failure; Male; Protein Binding; Rats; R | 2006 |
Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Anticonvulsants; Area Under Curve; Aspartate Am | 2007 |
Laparoscopy-assisted creation of a liver failure model in pigs.
Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Hepatic Artery; Hepatocytes; Laparoscopy; Liv | 2008 |
Preventive effect of taraxasteryl acetate from Inula britannica subsp. japonica on experimental hepatitis in vivo.
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Galactosamine; Inula; Liver F | 1995 |
[Effects of calcitriol and alfacalcidol on an osteoporosis model in rats with hepatic failure].
Topics: Animals; Bone Density; Calcitriol; Calcium; Carbon Tetrachloride; Disease Models, Animal; Female; Hu | 1999 |
Functional capacity of the cirrhotic liver after partial hepatectomy in the rat.
Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Hepatectomy; Liver Cirrhosis, Experimental; L | 1999 |
Functional impairment of sinusoidal membrane transport of organic cations in rats with CCl4-induced hepatic failure.
Topics: Animals; Carbon Tetrachloride; Cations; Hepatocytes; Liver Failure; Male; Quaternary Ammonium Compou | 2000 |
The role of hepatocyte transplantation to treat chronic liver failure.
Topics: Ammonia; Animals; Bilirubin; Carbon Tetrachloride; Cell Transplantation; Chronic Disease; Hepatocyte | 2000 |
Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration.
Topics: Animals; Bile Ducts; Carbon Tetrachloride; Cell Fractionation; Cell Line; Cells, Cultured; Chemokine | 2001 |
Effect of a herbal protein CI-1, purified from Cajanus indicus on the ultrastructural study of hepatocytes, in models of liver failure in mice.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Carbon Tetrachloride; Central Nervous System Depre | 2001 |
Kupffer cells inhibition prevents hepatic lipid peroxidation and damage induced by carbon tetrachloride.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Bilirubin; Carbon Tetrachloride; Cell Membrane; | 2001 |